Clinical Trials Directory

Trials / Sponsors / HistoSonics, Inc.

HistoSonics, Inc.

Industry · 10 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingThe Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy
Benign Prostatic Hyperplasia
N/A2026-03-20
RecruitingThe HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
Pancreas Cancer, Adenocarcinoma of the Pancreas, Pancreatic Cancer
N/A2024-12-10
RecruitingReal-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary
Liver Neoplasms, Primary Liver Cancer, Secondary Liver Cancer
—2024-10-14
Active Not RecruitingThe HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
Renal Cancer, Tumor, Solid, Kidney Cancer
N/A2024-01-04
CompletedThe HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Renal Cancer, Tumor, Solid, Kidney Cancer
N/A2023-03-23
Active Not RecruitingThe HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/
Liver Neoplasms, Hepatocellular Carcinoma, Liver Metastases
N/A2021-06-04
Active Not RecruitingThe HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy
Liver Neoplasms, Hepatocellular Carcinoma, Liver Metastases
N/A2021-01-27
CompletedStudy to Evaluate VORTX Rx (Theresa)
Carcinoma, Hepatocellular, Liver Metastases
N/A2018-03-21
TerminatedSafety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Benign Prostatic Hyperplasia (BPH)
N/A2013-07-01
WithdrawnSafety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)
Benign Prostatic Hyperplasia (BPH)
N/A2013-06-01